UNIVEST FINANCIAL Corp Has $5.19 Million Stock Holdings in Veeva Systems Inc. (NYSE:VEEV)

UNIVEST FINANCIAL Corp raised its stake in shares of Veeva Systems Inc. (NYSE:VEEV - Free Report) by 17.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 24,677 shares of the technology company's stock after purchasing an additional 3,595 shares during the quarter. UNIVEST FINANCIAL Corp's holdings in Veeva Systems were worth $5,188,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. MassMutual Private Wealth & Trust FSB increased its holdings in Veeva Systems by 72.5% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company's stock valued at $25,000 after purchasing an additional 50 shares in the last quarter. Centricity Wealth Management LLC acquired a new position in Veeva Systems during the 4th quarter worth about $25,000. Smithfield Trust Co increased its position in Veeva Systems by 145.5% in the 4th quarter. Smithfield Trust Co now owns 135 shares of the technology company's stock valued at $27,000 after acquiring an additional 80 shares in the last quarter. True Wealth Design LLC raised its stake in shares of Veeva Systems by 3,375.0% in the third quarter. True Wealth Design LLC now owns 139 shares of the technology company's stock worth $29,000 after acquiring an additional 135 shares during the last quarter. Finally, Avion Wealth lifted its position in shares of Veeva Systems by 635.0% during the fourth quarter. Avion Wealth now owns 147 shares of the technology company's stock worth $30,000 after purchasing an additional 127 shares in the last quarter. 88.20% of the stock is currently owned by institutional investors.

Remove Ads

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on VEEV shares. JPMorgan Chase & Co. boosted their target price on Veeva Systems from $218.00 to $249.00 and gave the stock a "neutral" rating in a research report on Thursday, March 20th. Scotiabank boosted their price target on shares of Veeva Systems from $240.00 to $245.00 and gave the stock a "sector perform" rating in a research note on Thursday, March 6th. Piper Sandler lifted their target price on shares of Veeva Systems from $280.00 to $290.00 and gave the stock an "overweight" rating in a report on Friday, December 6th. Needham & Company LLC restated a "buy" rating and issued a $270.00 price target on shares of Veeva Systems in a research report on Thursday, March 6th. Finally, The Goldman Sachs Group downgraded Veeva Systems from a "buy" rating to a "sell" rating and dropped their price objective for the company from $261.00 to $200.00 in a report on Thursday, January 23rd. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $256.52.

Veeva Systems Trading Down 1.4 %

Shares of NYSE VEEV traded down $3.38 during mid-day trading on Friday, hitting $234.10. The company had a trading volume of 947,518 shares, compared to its average volume of 1,037,921. Veeva Systems Inc. has a one year low of $170.25 and a one year high of $258.93. The company has a market capitalization of $38.01 billion, a PE ratio of 57.80, a price-to-earnings-growth ratio of 1.89 and a beta of 0.88. The firm has a 50-day simple moving average of $231.62 and a two-hundred day simple moving average of $222.87.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.